Abstract
Chronic inflammatory pathology of ENT organs is a group of diseases that an otorhinolaryngologist faces daily at an outpatient department. According to modern data, secondary immunodeficiency plays the main role in the chronization of inflammatory processes in ENT organs. For the purpose of correction, it is rational to add immunomodulators to standard therapy. An observational study was conducted on the comparative effectiveness of complex outpatient treatment of chronic tonsillitis and chronic rhinosinusitis using the immunomodulatory drug Galavit in clinical practice. Reliable data were obtained on the effect of the immunomodulator Galavit to increase in the duration of remission in chronic tonsillitis – up to 8 months on average, in chronic catarrhal rhinosinusitis – up to 8.5 months on average, a decrease in the frequency, duration and severity of the course of flu in chronic inflammatory pathology of ENT organs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
